Please assess the completion status of the following clinical trial:

Trial Title: A Study Comparing Radiofrequency Ablation and Hepatic Resection for Hepatocellular Carcinoma

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Age between 20 and 70 years~2. Child-Pugh class A (score 5-6)~3. Single hepatocellular carcinoma~4. Maximal diameter of the tumor from 2 to 4 cm when measured on MRI or CT (The diameter on MRI was measured prior to that on CT)~5. No previous treatment~6. Platelet count \> 80,000/mm3~Exclusion Criteria:~1. HCC abutting main hepatic veins or the first branches of the main portal vein~2. HCC abutting vessels ≥ 0.5 cm

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Hepatic resection (Type: EXPERIMENTAL): Hepatic resection is performed as a primary treatment for hepatocellular carcinoma.
- Radiofrequency ablation (Type: EXPERIMENTAL): Radiofrequency ablation is performed as a primary treatment for hepatocellular carcinoma.

Based on this trial design, predict the completion outcome and termination type (if applicable).